MDPI and ACS Style
Saavedra, C.; Vallejo, A.; Longo, F.; Serrano, J.J.; Fernández, M.; Gion, M.; López-Miranda, E.; MartÃnez-Jáñez, N.; Guerra, E.; Chamorro, J.;
et al. Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers 2023, 15, 2000.
https://doi.org/10.3390/cancers15072000
AMA Style
Saavedra C, Vallejo A, Longo F, Serrano JJ, Fernández M, Gion M, López-Miranda E, MartÃnez-Jáñez N, Guerra E, Chamorro J,
et al. Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers. 2023; 15(7):2000.
https://doi.org/10.3390/cancers15072000
Chicago/Turabian Style
Saavedra, Cristina, Alejandro Vallejo, Federico Longo, Juan José Serrano, MarÃa Fernández, MarÃa Gion, Elena López-Miranda, Noelia MartÃnez-Jáñez, Eva Guerra, Jesús Chamorro,
and et al. 2023. "Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors" Cancers 15, no. 7: 2000.
https://doi.org/10.3390/cancers15072000